 |
|
|
| |
Switching to Abacavir/Dolutegravir/Lamivudine Fixed Dose Combination (ABC/DTG/3TC FDC) from a PI, INI or NNRTI Based Regimen Maintains HIV Suppression
|
| |
| |
Reported by Jules Levin, NATAP
ICAAC 2015 Sept 17-21 2015 San Diego, CA
B. Trottier1, J. Lake2, K. Logue3, C. Brinson4, L. Santiago5, C. Brennan6, J. Koteff6, B. Wynne6, C. Granier7, M. Aboud8
1Clinique Med.e L'actuel, Montreal, QC, Canada, 2Univ. of California, Los Angeles, CA, 3CascAIDS Res., Toronto, ON, Canada, 4Central Texas Clin. Res., Austin, TX, 5Hope Clinical Res., San Juan, PR, 6ViiV Healthcare, Research Triangle Park, NC, 7GlaxoSmithKline, London, United Kingdom, 8ViiV Healthcare, London, United Kingdom
|
| |
|
|
|
|
|
